ARS Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has ARS Pharmaceuticals's balance sheet done over the years? Its assets were worth $233,188,000 last year, which is less than in the previous period. 1% of ARS Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $2,428,000, which means an decrease by -72% compared compared to last year.

Debt to Assets

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY): Debt to assets
2019 15647000 21.25M 135.81%
2020 26407000 40.45M 153.21%
2021 61446000 92.71M 150.89%
2022 281435000 8.54M 3.04%
2023 233188000 2.42M 1.04%

SPRY Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
70.97M210.51M60.06M24.52M9.97M
Short term investments
157.38M63.86M000
Net receivables
795K1.00M1K384K0
Inventory
0-1.00M-6.78M-2.61M0
Other current assets
2.57M3.31M7.44M4.08M552K
Total current assets
231.72M277.7M60.73M26.38M10.52M
Non-current assets:
Property, Plant and Equipment
824K774K693K23K4.56M
Goodwill
00000
Intangible assets
617K0000
Long term investments
0064.78M350K550K
Other non-current assets
21K2.96M-64.75M-348K0
Total non-current assets
1.46M3.73M716K25K5.11M
Total assets
233.18M281.43M61.44M26.40M15.64M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0283K1.45M3.51M0
Short term debt
474K230K3.62M2.55M12.29M
Total current liabilities
2.39M5.44M8.18M8.21M17.92M
Non-current liabilities:
Long term debt
37K251K5.41M7.46M0
Deferred tax
00000
Other non-current liabilities
02.85M76.12M27K0
Total non-current liabilities
37K3.10M84.52M32.24M3.32M
Total liabilities
2.42M8.54M92.71M40.45M21.25M
Data sourceData sourceData source